The Role of the Curcumin for Inducing Apoptosis in Acute Lymphoblastic Leukemia Cells: A Systematic Review

References

• Kavianpur M, Shahjahani M, Jaseb K, Kasar S, Saki N. Prognostic value and clinical significance of TCR rearrangements for MRD monitoring in ALL patients. Comp Clin Pathol. 2017;26(2):269–276. doi:10.1007/s00580-015-2207-8
   Google Scholar
• Nigro LL. Biology of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2013;35:245–252.
   PubMed Web of Science ®Google Scholar
• Vilas–Zornoza A, Agirre X, Martín-Palanco V, Martín-Subero JI, San José-Eneriz E, Garate L, Álvarez S, Miranda E, Rodríguez-Otero P, Rifón J, et al. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia. PloS One. 2011;6(2):e17012. doi:10.1371/journal.pone.0017012
   PubMed Web of Science ®Google Scholar
• Kavianpour M, Ketabchi N, Saki N. Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia. memo. 2017;10(3):164–166. doi:10.1007/s12254-017-0324-6
   Google Scholar
• de Moraes ACR, Maranho CK, Rauber GS, Santos‐Silva MC. Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy. J Clin Lab Anal. 2013;27(1):62–71. doi:10.1002/jcla.21563
   PubMed Web of Science ®Google Scholar
• Gillet J-P, Efferth T, Steinbach D, Hamels J, de Longueville F, Bertholet V, Remacle J. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 2004;64(24):8987–8993. doi:10.1158/0008-5472.CAN-04-1978
   PubMed Web of Science ®Google Scholar
• Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H, Wakabayashi K. Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis. 2000;21(10):1835–1841. doi:10.1093/carcin/21.10.1835
   PubMed Web of Science ®Google Scholar
• Lin J-K. Molecular targets of curcumin. In: The molecular targets and therapeutic uses of curcumin in health and disease. Springer; 2007. pp. 227–243.
   Google Scholar
• Teiten M-H, Eifes S, Dicato M, Diederich M. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel). 2010;2(1):128–162. doi:10.3390/toxins2010128
   PubMed Web of Science ®Google Scholar
• Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr. 2010;103(6):824–832. doi:10.1017/S0007114509992510
   PubMed Web of Science ®Google Scholar
• Shakor ABA, Atia M, Ismail IA, Alshehri A, El-Refaey H, Kwiatkowska K, Sobota A. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation. Biochim Biophys Acta. 2014;1841(12):1672–1682. doi:10.1016/j.bbalip.2014.09.006
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, et al. Phase I: clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 6847–6854. doi:10.1158/1078-0432.CCR-04-0744
   Google Scholar
• de Bruin EC, Medema JP. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev. 2008;34(8):737–749. doi:10.1016/j.ctrv.2008.07.001
   PubMed Web of Science ®Google Scholar
• Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003;9(1):161–168. doi:10.1089/107555303321223035
   PubMed Web of Science ®Google Scholar
• Gyuris M, Hackler L, Nagy LI, Alföldi R, Rédei E, Marton A, Vellai T, Faragó N, Ózsvári B, Hetényi A, et al. Mannich curcuminoids as potent anticancer agents. Arch Pharm Chem Life Sci. 2017;350(7):e1700005. doi:10.1002/ardp.201700005
   Web of Science ®Google Scholar
• Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci. 2017;131(15):1781–1799. doi:10.1042/CS20160935
   PubMed Web of Science ®Google Scholar
• Alizadeh F, Javadi M, Karami AA, Gholaminejad F, Kavianpour M, Haghighian HK. Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: a randomized clinical trial. Phytother Res. 2018;32(3):514–521. doi:10.1002/ptr.5998
   PubMed Web of Science ®Google Scholar
• Meghavarnam AK, Salah M, Sreepriya M, Janakiraman S. Growth inhibitory and proapoptotic effects of l-asparaginase from Fusarium culmorum ASP-87 on human leukemia cells (Jurkat). Fundam Clin Pharmacol. 2017;31(3):292–300. doi:10.1111/fcp.12257
   PubMed Web of Science ®Google Scholar
• Shanbhag VKL. Curcumin in chronic lymphocytic leukemia-a review. Asian Pac J Trop Biomed. 2017;7(6):505–512. doi:10.1016/j.apjtb.2017.05.003
   Web of Science ®Google Scholar
• Kumar P, Barua CC, Sulakhiya K, Sharma RK. Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD rats: potential role of curcumin in breast cancer chemotherapy. Front Pharmacol. 2017;8:132–158. doi:10.3389/fphar.2017.00132
   PubMed Web of Science ®Google Scholar
• Gunther JR, Chadha AS, Yang P, Munsell MF, Das P, Delclos ME, Foo WC, Kaur H, Clemons M, Mathew GG, et al. (S021) A phase 2 randomized double blinded study evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2017;98(2):E7. doi:10.1016/j.ijrobp.2017.02.057
   Web of Science ®Google Scholar
• Zhu J-Y, Yang X, Chen Y, Jiang Y, Wang S-J, Li Y, Wang X-Q, Meng Y, Zhu M-M, Ma X, et al. Curcumin suppresses lung cancer stem cells via inhibiting Wnt/β-catenin and sonic hedgehog pathways. Phytother Res. 2017;31(4):680–688. doi:10.1002/ptr.5791
   PubMed Web of Science ®Google Scholar
• Indran IR, Tufo G, Pervaiz S, Brenner C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta. 2011;1807(6):735–745. doi:10.1016/j.bbabio.2011.03.010
   PubMed Web of Science ®Google Scholar
• Yang J, Wu L-J, Tashino S-I, Onodera S, Ikejima T. Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res. 2008;42(5):492–504. doi:10.1080/10715760802112791
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BKH, Kumar AP, Sethi G, et al. The multifaceted role of curcumin in cancer prevention and treatment. Molecules. 2015;20(2):2728–2769. doi:10.3390/molecules20022728
   PubMed Web of Science ®Google Scholar
• Hackler L, Ózsvári B, Gyuris M, Sipos P, Fábián G, Molnár E, Marton A, Faragó N, Mihály J, Nagy LI, et al. The curcumin analog C-150, influencing NF-κB, UPR and Akt/Notch pathways has potent anticancer activity in vitro and in vivo. PLoS One. 2016;11(3):e0149832. doi:10.1371/journal.pone.0149832
   PubMed Web of Science ®Google Scholar
• Deng Y, Lu X, Wang L, Li T, Ding Y, Cao H, Zhang Y, Guo X, Yu G. Curcumin inhibits the AKT/NF-κB signaling via CpG demethylation of the promoter and restoration of NEP in the N2a cell line. AAPS J. 2014;16(4):649–657. doi:10.1208/s12248-014-9605-8
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013;39(1):27–36. doi:10.1002/biof.1065
   PubMed Web of Science ®Google Scholar
• Mishra D, Singh S, Narayan G. Curcumin induces apoptosis in pre-B acute lymphoblastic leukemia cell lines via PARP-1 cleavage. Asian Pac J Cancer Prev. 2016;17(8):3865–3869.
   PubMedGoogle Scholar
• William BM, Goodrich A, Peng C, Li S. Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia. Hematology. 2008;13(6):333–343. doi:10.1179/102453308X343437
   PubMed Web of Science ®Google Scholar
• Pimentel-Gutiérrez HJ, Bobadilla-Morales L, Barba-Barba CC, Ortega-De-La-Torre C, Sánchez-Zubieta FA, Corona-Rivera JR, González-Quezada BA, Armendáriz-Borunda JS, Silva-Cruz R, Corona-Rivera A, et al. Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-κB. Oncol Lett. 2016;12(5):4117–4124. doi:10.3892/ol.2016.5217
   PubMed Web of Science ®Google Scholar
• Wang H, Geng Q-R, Wang L, Lu Y. Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leuk Lymphoma. 2012;53(7):1376–1382. doi:10.3109/10428194.2011.649478
   PubMed Web of Science ®Google Scholar
• Hussain AR, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, Al Kuraya K, Uddin S. Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias. Apoptosis. 2006;11(2):245–254. doi:10.1007/s10495-006-3392-3
   PubMed Web of Science ®Google Scholar
• Rajasingh J, Raikwar HP, Muthian G, Johnson C, Bright JJ. Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem Biophys Res Commun. 2006;340(2):359–368. doi:10.1016/j.bbrc.2005.12.014
   PubMed Web of Science ®Google Scholar
• Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. 2011;68(1):157–164. doi:10.1007/s00280-010-1470-2
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 2005;11(20):7490–7498. doi:10.1158/1078-0432.CCR-05-1192
   PubMed Web of Science ®Google Scholar
• Kang HJ, Lee SH, Price JE, Kim LS. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Breast J. 2009;15(3):223–229. doi:10.1111/j.1524-4741.2009.00709.x
   PubMed Web of Science ®Google Scholar
• Piccaluga PP, Malagola M, Rondoni M, Ottaviani E, Testoni N, Laterza C, Visani G, Pileri SA, Martinelli G, Baccarani M, et al. Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation. Leuk Lymphoma. 2006;47(3):469–472. doi:10.1080/10428190500331261
   PubMed Web of Science ®Google Scholar
• Al Ustwani O, Gupta N, Bakhribah H, Griffiths E, Wang E, Wetzler M. Clinical updates in adult acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 2016;99:189–199. doi:10.1016/j.critrevonc.2015.12.007
   PubMed Web of Science ®Google Scholar
• Kang Z-J, Liu Y-F, Xu L-Z, Long Z-J, Huang D, Yang Y, Liu B, Feng J-X, Pan Y-J, Yan J-S, et al. The Philadelphia chromosome in leukemogenesis. Chin J Cancer. 2016;35:48. doi:10.1186/s40880-016-0108-0
   PubMed Web of Science ®Google Scholar
• Guo Y, Li Y, Shan Q, He G, Lin J, Gong Y. Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph + acute lymphoblastic leukemia. Int J Biochem Cell Biol. 2015;65:1–11. doi:10.1016/j.biocel.2015.05.003
   PubMed Web of Science ®Google Scholar
• Jasseb K, Kavianpour M, Asl J, Arani Z, Azad V. T-ALL with TEL/aml1 translocation, aberrant expression of CD19 and 33: case report and literature review. Ann Bone Marrow Res. 2016;1(1):001–004. doi:10.17352/abmr.000001
   Google Scholar
• Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D’Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005;224(1):53–65. doi:10.1016/j.canlet.2004.10.051
   PubMed Web of Science ®Google Scholar
• Allegra A, Speciale A, Molonia MS, Guglielmo L, Musolino C, Ferlazzo G, Costa G, Saija A, Cimino F. Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways. Toxicol In Vitro. 2018;47:186–194. doi:10.1016/j.tiv.2017.12.001
   PubMed Web of Science ®Google Scholar
• Akaishi T, Abe K. cnb-001, a synthetic pyrazole derivative of curcumin, suppresses lipopolysaccharide-induced nitric oxide production through the inhibition of Nf-κb and p38 Mapk pathways in microglia. Eur J Pharmacol. 2018;819:190–197. doi:10.1016/j.ejphar.2017.12.008
   PubMed Web of Science ®Google Scholar
• Dai J, Gu L, Su Y, Wang Q, Zhao Y, Chen X, Deng H, Li W, Wang G, Li K, et al. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways. Int Immunopharmacol. 2018;54:177–187. doi:10.1016/j.intimp.2017.11.009
   PubMed Web of Science ®Google Scholar
• Chang Z, Xing J, Yu X. Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway. Tumour Biol. 2014;35(1):753–758. doi:10.1007/s13277-013-1102-7
   PubMedGoogle Scholar
• Teymouri M, Pirro M, Johnston TP, Sahebkar A. Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: a review of chemistry, cellular, molecular, and preclinical features. Biofactors. 2017;43(3):331–346. doi:10.1002/biof.1344
   PubMed Web of Science ®Google Scholar
• Gong C, Lu C, Li B, Shan M, Wu G. Injectable dopamine-modified poly(α,β-aspartic acid) nanocomposite hydrogel as bioadhesive drug delivery system . J Biomed Mater Res A. 2017;105(4):1000–1008. doi:10.1002/jbm.a.35931
   PubMed Web of Science ®Google Scholar
• Wang H, Sun R, Chi Z, Li S, Hao L. Curcumin pretreatment prevents hydrogen peroxide-induced oxidative stress through enhanced mitochondrial function and deactivation of Akt/Erk signaling pathways in rat bone marrow mesenchymal stem cells. Mol Cell Biochem. 2017;433(1–2):1–9. doi:10.1007/s11010-017-3011-3
   PubMed Web of Science ®Google Scholar
• Tharkar-Promod S, Johnson DP, Bennett SE, Dennis EM, Banowsky BG, Jones SS, Shearstone JR, Quayle SN, Min C, Jarpe M, et al. HDAC1, 2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Leukemia. 2018;32(1):49–60. doi:10.1038/leu.2017.174
   PubMed Web of Science ®Google Scholar
• Shah AJ, Prasanth Kumar S, Rao MV, Pandya HA. Ameliorative effects of curcumin towards cyclosporine-induced genotoxic potential: an in vitro and in silico study. Drug Chem Toxicol. 2018;41(3):259-269..
   Web of Science ®Google Scholar
• Pignanelli C, Ma D, Noel M, Ropat J, Mansour F, Curran C, Pupulin S, Larocque K, Wu J, Liang G, et al. Selective targeting of cancer cells by oxidative vulnerabilities with novel curcumin analogs. Sci Rep. 2017;7(1):1–25. doi:10.1038/s41598-017-01230-4
   PubMed Web of Science ®Google Scholar
• Esfini-Farahani M, Farshdousti-Hagh M, Bashash D, Esmaeili S, Dehghan-Nayeri N, Yazdanpanah S, Gharehbaghian A. Analysis of cytotoxic activity and synergistic effect of curcuma longa extract in combination with prednisolone on acute lymphoblastic leukemia cell lines. Int J Cancer Manag. 2017;10(11):20–29. doi:10.5812/ijcm.14174
   Web of Science ®Google Scholar
• Brown RE, Konopka KE, Weerasinghe P, Jaitly V, Dasgupta A, McGuire MF, Nguyen ND. Morphoproteomics identifies SIRT1 and EZH2 pathways as commonalities in B-cell acute lymphoblastic leukemia: pathogenetic implications and opportunities for therapeutic intervention. Ann Clin Lab Sci. 2017;47(1):3–9.
   PubMed Web of Science ®Google Scholar
• Morishita N, Tsukahara H, Chayama K, Ishida T, Washio K, Miyamura T, Yamashita N, Oda M, Morishima T. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia . Pediatr Blood Cancer. 2012;59(1):83–89. doi:10.1002/pbc.24034
   PubMed Web of Science ®Google Scholar
• Bordoloi D, Kunnumakkara AB. The potential of curcumin: a multitargeting agent in cancer cell chemosensitization. Role of nutraceuticals in cancer chemosensitization. Academic Press; 2018. pp. 31–60.
   Google Scholar
• Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A, Yu Y. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Oncol Rep. 2018;39(3):1523-1531. doi:10.3892/or.2018.6188
   Web of Science ®Google Scholar
• Seo J-A, Kim B, Dhanasekaran DN, Tsang BK, Song YS. Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2016;371(1):30–37. doi:10.1016/j.canlet.2015.11.021
   PubMed Web of Science ®Google Scholar
• Liu G-Y, Sun Y-Z, Zhou N, Du X-M, Yang J, Guo S-J. 3,3'-OH curcumin causes apoptosis in HepG2 cells through ROS-mediated pathway. Eur J Med Chem. 2016;112:157–163. doi:10.1016/j.ejmech.2016.02.019
   PubMed Web of Science ®Google Scholar
• Pagliarini R, Shao W, Sellers WR. Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure. EMBO Rep. 2015;16(3):e201439949. doi:10.15252/embr.201439949
   Web of Science ®Google Scholar
• Mirzaei H, Naseri G, Rezaee R, Mohammadi M, Banikazemi Z, Mirzaei HR, Salehi H, Peyvandi M, Pawelek JM, Sahebkar A, et al. Curcumin: a new candidate for melanoma therapy? Int J Cancer. 2016;139(8):1683–1695. doi:10.1002/ijc.30224
   PubMed Web of Science ®Google Scholar
• Taverna S, Giallombardo M, Pucci M, Flugy A, Manno M, Raccosta S, Rolfo C, De Leo G, Alessandro R. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget. 2015;6(26):21918–21933. doi:10.18632/oncotarget.4204
   PubMedGoogle Scholar
• Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol. 2017;9:31–45. doi:10.2147/JEP.S70568
   PubMedGoogle Scholar
• Villarino AV, Kanno Y, Ferdinand JR, O’Shea JJ. Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol. 2015;194(1):21–27. doi:10.4049/jimmunol.1401867
   PubMed Web of Science ®Google Scholar
• Thomas S, Snowden J, Zeidler M, Danson S. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015;113(3):365–371. doi:10.1038/bjc.2015.233
   PubMed Web of Science ®Google Scholar
• Price FD, von Maltzahn J, Bentzinger CF, Dumont NA, Yin H, Chang NC, Wilson DH, Frenette J, Rudnicki MA. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat Med. 2014;20(10):1174–1181. doi:10.1038/nm.3655
   PubMed Web of Science ®Google Scholar
• Hu A, Huang J-J, Jin X-J, Li J-P, Tang Y-J. Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway. Am J Cancer Res. 2015;5:278.
   PubMed Web of Science ®Google Scholar
• Sen M, Pollock NI, Black J, DeGrave KA, Wheeler S, Freilino ML, Joyce S, Lui VWY, Zeng Y, Chiosea SI, et al. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Neoplasia. 2015;17(3):256–264. doi:10.1016/j.neo.2015.01.003
   PubMed Web of Science ®Google Scholar
• Zhao H-M, Xu R, Huang X-Y, Cheng S-M, Huang M-F, Yue H-Y, Wang X, Zou Y, Lu A-P, Liu D-Y, et al. Curcumin suppressed activation of dendritic cells via JAK/STAT/SOCS signal in mice with experimental colitis. Front Pharmacol. 2016;7:455. doi:10.3389/fphar.2016.00455
   PubMed Web of Science ®Google Scholar